Sanket Koul

New UCMPMD amendment allows overseas training without prior approval in cases where equipment or expertise is unavailable domestically, shifting compliance responsibility to firms

Co-working firm expects expansion from 10.1 msf base, supported by strong office absorption, rising demand for managed workspaces, and visibility of future supply

Diagnostics firm reports profit decline due to prior-year tax benefit, while revenue growth remains strong on higher sample volumes and improved test mix

Pharma major says seized fake Mounjaro in Gurugram did not originate from its supply chain, urges vigilance and purchase only through authorised channels

Experts laud timing of Dubai's move to ease investor visa norms, which could revive interest among Indian buyers amid recent geopolitical uncertainty

DRL is the first company to receive market authorisation for a generic semaglutide injection in Canada. It is the first generic semaglutide to be approved in a G7 country

The Delhi-based developer plans to set up a wholly owned subsidiary in Singapore to offer data centre and cloud services, marking its first overseas expansion amid rising demand

Labour Ministry calls for urgent heatwave protection measures for workers

The deal was held up in court amid Daiichi Sankyo's long-running dispute with the Singh brothers over its purchase of Ranbaxy Laboratories more than a decade ago

Rising input costs amid West Asia tensions may shrink affordable housing supply, as thin margins deter developers despite strong demand in urban India

Medical device makers welcome India-NZ FTA for easing market access and exports, but flag absence of CDSCO in regulatory recognition framework as a key gap

Brazil's regulator Anvisa rejects DRL and Cipla's generic GLP-1 drug filings, citing unmet technical requirements on efficacy, safety and quality

Rising API prices from China and feedstock disruptions amid the West Asia crisis are tightening cost pressures on India's pharma sector despite temporary inventory buffers

The Department of Pharmaceuticals plans to approach MoPNG and the Fertilisers Department to secure ammonia supplies for drugmakers amid shortages triggered by West Asia tensions

Multinational medtech firms have urged the Centre to revise local content calculations under PPOs, proposing inclusion of R&D and maintenance costs to widen eligibility in tenders

The Centre has raised the age limit and broadened eligibility norms for appointing the Drug Controller General of India to address a shortage of qualified candidates

Lohia Worldspace plans Delhi entry with a Kirti Nagar high-rise and expands in Moradabad, targeting multiple projects and investments in FY27

Max Healthcare plans to expand capacity to 6,500 beds by FY27 and boost medical tourism through overseas offices and new facilities, including a 400-bed tower in Delhi

On an FY basis, India's pharma exports remained flat at $31.11 billion in FY26, a 2.13 per cent rise from $30.47 billion in FY25

Signature Global has partnered Tonino Lamborghini to develop a branded residences project in Gurugram, with a planned investment of Rs 2,890 crore and expected GDV of Rs 4,000 crore